Abstract
It has been hypothesized that MDMA and substances that possess a psychopharmacological effect similar to MDMA are members of a novel pharmacological class named entactogens [1–3]. In this chapter evidence will be presented to support this, through a discussion of the data acquired in efforts directed toward testing this hypothesis. Although these studies are far from complete, the results gathered thus far, together with those from other laboratories, support the view that the pharmacology of entactogens is clearly different from other known classes of compounds.
Keywords
- Discriminative Stimulus
- Drug Discrimination
- Training Dose
- Complete Substitution
- Discriminative Stimulus Property
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Nichob. D.E., Hoffman. A.J. Obetlender. R.A., Jacob III. P., and Shulgin. A T., 1986 Derivatives of Hl.3-bemodioxol-5-yl)-2-butaiiainMe: Representatives of a rove! therapeutic class. J. Med. Chein. 29: 2009–2015.
Nichols. D.E. 1986 Differences between the mechanisms of action of MDV.A. MBDB. and the classical hallucinogens. Identification of a new therapeutic class: Entactogens. J. Psychoactive Drugs 18: 305–313.
Oberlender. R and Nichob. D.E., 1988 Drug discrimination studies with MDMA and amphetamine. Psychophatmacology 95: 71–76.
Jaffe. J.H., 1985. Drug addiction and drug abuse. In The Pharmacological Basis of Therapeutics, Seventh Edition. (Gilnun. A G., Goodman. L.S., Rail. T.W. Murad. F. cds). New York. MacmilLan Publishing Company, pp. 523–581
Werner. N., 1980. Norepinephrine, epinephrine, and the sypalhominietic amines. In The Pharmacological Basis of Therapeutics, Sixth Edition, ( Gilrnan, A.G., Gooiman. L.S. and Gilman. A., cds.) New York: Macmillan. pp 138–175
Greer. G. and Tolbcrt. R., 1986 Subjective reports of the effects of MDMA in a clinical setting. J. Psychoactive Drugs 18: 319–327.
Stolerman. I P. and D’Mello G.D. 1981 Role of training conditions in dsenmination of central nervous system stimulants by rats. Psychopharnuoology 73: 295–303.
Barry. H., 1974 Classification of drugs according to their discriminate effects in rats. Fed. Proc. 33: 1814–1824.
Overton. D.A., (1984). State dependent learning and drug discrimuiatioits In HanJkodt of PyHhopharmHelegy. Vol. 18 (lvcrsen. L.L., Ivcrscn. S.D and Snyder. S.H.cds.) New York: Plenum Press, pp. 59–126
Weil. A., 1976 The love drug. J. Psychoactive Drugs 8: 335–337
Turek. I S., Soskiri. R A. and Kurland. A A., 1974 Meihyleitedioxyamphctainine (MDA) Subjective effects J Psychedelic Dnigs 6:7–14128 7. Structure-Activity Relationships of MDMA and Related Compounds
Shannon, H.E., 1980. MDA and DOM: Substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat. Psychopharnucology 67: 311–312.
Glennon, R.A., Rosccrans. J A., and Young, R. 1981 Behavioral properties of psychoactive phcnylisopiopylainincs in ran Eur J Pharmacol. 76: 353–360.
Glctinon. R.A. and Young. R., 19R4. MDA: An agent that produces stimulus effects similar to those of 3.4-DMA. LSD and cocaine. Fair. J. Pharmacol. 99: 249–250.
Glennon. R.A and Young. R., 1984. MDA: A psychoactive agent with dual stimulus effects. Life So. 34: 379–383
Shulgui. A.T., 1978. Psychotomimetic drugs Structure-activity relationships. In Handbook of Psychopharmacology. Vol 11 (lversen, L.L., lversen, S I), and Snyder. S.H., eds.). New York: Plenum, pp. 243–333.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Nichols, D.F., Oberlender, R. (1990). Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents?. In: Peroutka, S.J. (eds) Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA. Topics in the Neurosciences, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1485-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1485-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8799-5
Online ISBN: 978-1-4613-1485-1
eBook Packages: Springer Book Archive